Abstract
Spastic paraplegia 35 (SPG35) is a recessive condition characterized by childhood onset, progressive course, complicated by dystonia, dysarthria, cognitive impairment, and epilepsy. Mutations in the FA2H gene have been described in several families, leading to the proposal of a single entity, named fatty acid hydrolase-associated neurodegeneration (FAHN). Several reports have described a polymorphic radiological picture with white matter lesions of various degrees and a distinct form of neurodegeneration with brain iron accumulation. While we reviewed the pertinent literature, we also report three new patients with SPG35, highlighting the possible absence of white matter lesions even after a long neuroimaging follow-up. Three-dimensional modeling of the mutated proteins was helpful to elucidate the role of the site of mutations and the correlation with the residual enzyme activity as determined in cultured skin fibroblasts.
References
Harding A (1993) Hereditary spastic paraplegias. Semin Neurol 13(04):333–336. https://doi.org/10.1055/s-2008-1041143
Lo Giudice T, Lombardi F, Santorelli FM, Kawarai T, Orlacchio A (2014) Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms. Exp Neurol 261:518–539
Klebe S, Stevanin G, Depienne C (2015) Clinical and genetic heterogeneity in hereditary spastic paraplegias: from SPG1 to SPG72 and still counting. Rev Neurol (Paris) 171:505–530
Fink JK (2013) Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol 126(3):307–328. https://doi.org/10.1007/s00401-013-1115-8
Alderson NL, Rembiesa BM, Walla MD, Bielawska A, Bielawski J, Hama H (2004) The human FA2H gene encodes a fatty acid 2-hydroxylase. J Biol Chem 279(47):48562–48568. https://doi.org/10.1074/jbc.M406649200
Hama H (2010) Fatty acid 2-hydroxylation in mammalian sphingolipid biology. Biochim Biophys Acta-Mol Cell Biol Lipids 1801(4):405–414. https://doi.org/10.1016/j.bbalip.2009.12.004
Dick KJ, Eckhardt M, Paisán-Ruiz C, Alshehhi AA, Proukakis C, Sibtain NA, Maier H, Sharifi R, Patton MA, Bashir W, Koul R, Raeburn S, Gieselmann V et al (2010) Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35). Hum Mutat 31(4):E1251–E1260. https://doi.org/10.1002/humu.21205
Edvardson S, Hama H, Shaag A, Gomori JM, Berger I, Soffer D, Korman SH, Taustein I, Saada A, Elpeleg O (2008) Mutations in the fatty acid 2-hydroxylase gene are associated with Leukodystrophy with spastic Paraparesis and dystonia. Am J Hum Genet 83(5):643–648. https://doi.org/10.1016/j.ajhg.2008.10.010
Kruer MC, Paisán-Ruiz C, Boddaert N, Yoon MY, Hama H, Gregory A, Malandrini A, Woltjer RL, Munnich A, Gobin S, Polster BJ, Palmeri S, Edvardson S, Hardy J, Houlden H, Hayflick SJ (2010) Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Ann Neurol 68(5):611–618. https://doi.org/10.1002/ana.22122
Pierson TM, Simeonov DR, Sincan M, Adams DA, Markello T, Golas G, Fuentes-Fajardo K, Hansen NF, Cherukuri PF, Cruz P, Blackstone C, Tifft C, Boerkoel CF et al (2012) Exome sequencing and SNP analysis detect novel compound heterozygosity in fatty acid hydroxylase-associated neurodegeneration. Eur J Hum Genet 20(4):476–479. https://doi.org/10.1038/ejhg.2011.222
Cao L, Huang XJ, Chen CJ, Di Chen S (2013) A rare family with hereditary spastic paraplegia type 35 due to novel FA2H mutations: a case report with literature review. J Neurol Sci 329(1-2):1–5. https://doi.org/10.1016/j.jns.2013.02.026
Garone C, Pippucci T, Cordelli DM, Zuntini R, Castegnaro G, Marconi C, Graziano C, Marchiani V, Verrotti A, Seri M, Franzoni E (2011) FA2H-related disorders: A novel c.270+3A>T splice-site mutation leads to a complex neurodegenerative phenotype. Dev Med Child Neurol 53:958–961
Pensato V, Castellotti B, Gellera C, Pareyson D, Ciano C, Nanetti L, Salsano E, Piscosquito G, Sarto E, Eoli M, Moroni I, Soliveri P, Lamperti E, Chiapparini L, di Bella D, Taroni F, Mariotti C (2014) Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48. Brain 137(7):1907–1920. https://doi.org/10.1093/brain/awu121
Tessa A, Battini R, Rubegni A, Storti E, Marini C, Galatolo D, Pasquariello R, Santorelli FM (2016) Identification of mutations in AP4S1/SPG52 through next generation sequencing in three families. Eur J Neurol 23(10):1580–1587. https://doi.org/10.1111/ene.13085
Guerois R, Nielsen JE, Serrano L (2002) Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. J Mol Biol 320(2):369–387. https://doi.org/10.1016/S0022-2836(02)00442-4
Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA (2001) Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A 98(18):10037–10041. https://doi.org/10.1073/pnas.181342398
Pires DE, Blundell TL, Ascher DB (2016) mCSM-lig: quantifying the effects of mutations on protein-small molecule affinity in genetic disease and emergence of drug resistance. Sci Rep 6(1):29575. https://doi.org/10.1038/srep29575
Dick KJ, Al-Mjeni R, Baskir W, Koul R, Simpson MA, Patton MA, Raeburn S, Crosby AH (2008) A novel locus for an autosomal recessive hereditary spastic paraplegia (SPG35) maps to 16q21-q23. Neurology 71(4):248–252. https://doi.org/10.1212/01.wnl.0000319610.29522.8a
Zaki MS, Selim L, Mansour L, Mahmoud IG, Fenstermaker AG, Gabriel SB, Gleeson JG (2015) Mutations in FA2H in three Arab families with a clinical spectrum of neurodegeneration and hereditary spastic paraparesis. Clin Genet 88(1):95–97. https://doi.org/10.1111/cge.12516
Donkervoort S, Dastgir J, Hu Y, Zein WM, Marks H, Blackstone C, Bönnemann CG (2014) Phenotypic variability of a likely FA2H founder mutation in a family with complicated hereditary spastic paraplegia. Clin Genet 85(4):393–395. https://doi.org/10.1111/cge.12185
Liao X, Luo Y, Zhan Z, Du J, Hu Z, Wang J, Guo J, Yan X (2015) SPG35 contributes to the second common subtype of AR-HSP in China: frequency analysis and functional characterization of FA2H gene mutations. Clin Genet 87(1):85–89. https://doi.org/10.1111/cge.12336
Tonelli A, D’Angelo MG, Arrigoni F, Brighina E, Arnoldi A, Citterio A, Bresolin N, Bassi MT (2012) Atypical adult onset complicated spastic paraparesis with thin corpus callosum in two patients carrying a novel FA2H mutation. Eur J Neurol 19:e127–e129
Rupps R, Hukin J, Balicki M, Mercimek-Mahmutoglu S, Rolfs A, Dias C (2013) Novel mutations in FA2H -associated neurodegeneration. J Child Neurol 28(11):1500–1504. https://doi.org/10.1177/0883073812458538
Aguirre-Rodriguez FJ, Lucenilla MIR, Alvarez-Cubero MJ, Mata C, Entrala-Bernal C, Fernandez-Rosado F (2015) Novel FA2H mutation in a girl with familial spastic paraplegia. J Neurol Sci 357(1-2):332–334. https://doi.org/10.1016/j.jns.2015.07.042
Soehn AS, Rattay TW, Beck-Wödl S, Schäferhoff K, Monk D, Döbler-Neumann M, Hörtnagel K, Schlüter A, Ruiz M, Pujol A, Züchner S, Riess O, Schüle R, Bauer P, Schöls L (2016) Uniparental disomy of chromosome 16 unmasks recessive mutations of FA2H/SPG35 in 4 families. Neurology 87(2):186–191. https://doi.org/10.1212/WNL.0000000000002843
Kara E, Tucci A, Manzoni C, Lynch DS, Elpidorou M, Bettencourt C, Chelban V, Manole A, Hamed SA, Haridy NA, Federoff M, Preza E, Hughes D, Pittman A, Jaunmuktane Z, Brandner S, Xiromerisiou G, Wiethoff S, Schottlaender L, Proukakis C, Morris H, Warner T, Bhatia KP, Korlipara LVP, Singleton AB, Hardy J, Wood NW, Lewis PA, Houlden H (2016) Genetic and phenotypic characterization of complex hereditary spastic paraplegia. Brain 139(7):1904–1918. https://doi.org/10.1093/brain/aww111
Magariello A, Russo C, Citrigno L, Züchner S, Patitucci A, Mazzei R, Conforti FL, Ferlazzo E, Aguglia U, Muglia M (2017) Exome sequencing reveals two FA2H mutations in a family with a complicated form of hereditary spastic paraplegia and psychiatric impairments. J Neurol Sci 372:347–349. https://doi.org/10.1016/j.jns.2016.11.069
Acknowledgments
The authors thank Doctor Catherine J. Wrenn who provided expert editorial assistance. This research was supported in part by the E-RARE-3 Joint Transnational Call grant “Preparing therapies for autosomal recessive ataxias” (PREPARE) (MoH; project 3398 to FMS).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
This study was approved by the Tuscany Regional Pediatric Ethics committee. All the procedures complied with the Helsinki Declaration of 1975. Genetic studies were performed after parental written informed consent.
Conflict of interest
The authors declare that they have no conflict of interests.
Additional information
The authors wish it to be known that, in their opinion, the first three authors should be regarded as joint First Authors.
Electronic supplementary material
Supplementary Fig. S1
(GIF 214 kb)
Supplementary Fig. S2
(GIF 143 kb)
Supplementary Table S1
(XLS 42 kb)
Supplementary Table S2
(DOCX 30 kb)
ESM 1
(DOCX 38 kb)
Rights and permissions
About this article
Cite this article
Mari, F., Berti, B., Romano, A. et al. Clinical and neuroimaging features of autosomal recessive spastic paraplegia 35 (SPG35): case reports, new mutations, and brief literature review. Neurogenetics 19, 123–130 (2018). https://doi.org/10.1007/s10048-018-0538-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10048-018-0538-8